{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:53:39Z","timestamp":1770508419085,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":226,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/bjd.13277","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T15:46:19Z","timestamp":1405611979000},"page":"754-759","source":"Crossref","is-referenced-by-count":7,"title":["Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial"],"prefix":"10.1093","volume":"172","author":[{"given":"D.M.W.","family":"Balak","sequence":"first","affiliation":[{"name":"Department of Dermatology; Erasmus Medical Center; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fallah-Arani","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus Medical Center; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Venema","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus Medical Center; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.M.","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus Medical Center; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.B.","family":"Thio","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Erasmus Medical Center; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,1,18]]},"reference":[{"key":"10.1111\/bjd.13277-BIB0001|bjd13277-cit-0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2004.11.003","article-title":"Dimethylfumarate for psoriasis: more than a dietary curiosity","volume":"11","author":"Mrowietz","year":"2005","journal-title":"Trends Mol Med"},{"issue":"Suppl. 2","key":"10.1111\/bjd.13277-BIB0002|bjd13277-cit-0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","article-title":"European S3-guidelines on the systemic treatment of psoriasis vulgaris","volume":"23","author":"Pathirana","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13277-BIB0003|bjd13277-cit-0003","first-page":"603","article-title":"Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis - a retrospective study (FUTURE)","volume":"7","author":"Reich","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.13277-BIB0004|bjd13277-cit-0004","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2133.2010.10195.x","article-title":"Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial","volume":"164","author":"Fallah","year":"2011","journal-title":"Br J\u00a0Dermatol"},{"key":"10.1111\/bjd.13277-BIB0005|bjd13277-cit-0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1468-3083.2012.04596.x","article-title":"Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions","volume":"27","author":"Inzinger","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13277-BIB0006|bjd13277-cit-0006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2133.2003.05433.x","article-title":"Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13277-BIB0007|bjd13277-cit-0007","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2133.2009.09267.x","article-title":"Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study","volume":"162","author":"Wain","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13277-BIB0008|bjd13277-cit-0008","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2230.2012.04351.x","article-title":"Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experience","volume":"37","author":"Heelan","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.13277-BIB0009|bjd13277-cit-0009","doi-asserted-by":"crossref","first-page":"21769","DOI":"10.5070\/D3203021769","article-title":"Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011","volume":"20","author":"Zweegers","year":"2014","journal-title":"Dermatol Online J"},{"issue":"11 Suppl.","key":"10.1111\/bjd.13277-BIB0010|bjd13277-cit-0010","first-page":"228","article-title":"Management strategies for flushing and gastrointestinal events associated with BG-12 (dimethyl fumarate): expert panel recommendations","volume":"19","author":"Phillips","year":"2013","journal-title":"Multiple Sclerosis"},{"key":"10.1111\/bjd.13277-BIB0011|bjd13277-cit-0011","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/85.5.1185","article-title":"Histamine and histamine intolerance","volume":"85","author":"Maintz","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/bjd.13277-BIB0012|bjd13277-cit-0012","first-page":"1","article-title":"Cetirizine modulates\u00a0adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients","volume":"25","author":"Pestelli","year":"2003","journal-title":"Int J Tissue React"},{"key":"10.1111\/bjd.13277-BIB0013|bjd13277-cit-0013","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.intimp.2004.01.022","article-title":"Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders","volume":"4","author":"Namazi","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/bjd.13277-BIB0014|bjd13277-cit-0014","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2125.2004.02145.x","article-title":"Pharmacokinetics of oral fumarates in healthy subjects","volume":"58","author":"Litjens","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/bjd.13277-BIB0015|bjd13277-cit-0015","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","article-title":"Improved discriminative and evaluative capability of a refined version of Skindex, a\u00a0quality-of-life instrument for patients with skin diseases","volume":"133","author":"Chren","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13277-BIB0016|bjd13277-cit-0016","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/jdv.12090","article-title":"Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life","volume":"27","author":"Prinsen","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13277-BIB0017|bjd13277-cit-0017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/jid.2011.354","article-title":"Dermatology Life Quality Index: time to move forward","volume":"132","author":"Nijsten","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13277-BIB0018|bjd13277-cit-0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000351843","article-title":"The clinical use of cetirizine in the treatment of allergic rhinitis","volume":"92","author":"Zhang","year":"2013","journal-title":"Pharmacology"},{"key":"10.1111\/bjd.13277-BIB0019|bjd13277-cit-0019","first-page":"97","article-title":"Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study","volume":"23","author":"Pestelli","year":"2001","journal-title":"Int J Tissue React"},{"key":"10.1111\/bjd.13277-BIB0020|bjd13277-cit-0020","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.13277-BIB0021|bjd13277-cit-0021","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.clinthera.2013.08.009","article-title":"Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers","volume":"35","author":"Sheikh","year":"2013","journal-title":"Clin Ther"},{"key":"10.1111\/bjd.13277-BIB0022|bjd13277-cit-0022","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s004030050251","article-title":"Influence of monomethylfumarate on monocytic cytokine formation - explanation for adverse and therapeutic effects in psoriasis?","volume":"289","author":"Asadullah","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.13277-BIB0023|bjd13277-cit-0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/000155501317208408","article-title":"Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis","volume":"81","author":"Friedrich","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.13277-BIB0024|bjd13277-cit-0024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5414\/ALX01523","article-title":"Dimethylfumarate in the treatment of psoriasis - a hitherto unnoticed source of sensitization? A case series and review of the literature","volume":"36","author":"Hessam","year":"2013","journal-title":"Allergologie"},{"key":"10.1111\/bjd.13277-BIB0025|bjd13277-cit-0025","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA2LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1111\/bjd.13277-BIB0026|bjd13277-cit-0026","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-4362.1995.tb00630.x","article-title":"Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions","volume":"34","author":"Caproni","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13277-BIB0027|bjd13277-cit-0027","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2133.1995.tb06923.x","article-title":"Systemic high-dose ranitidine in the treatment of psoriasis: an open prospective clinical trial","volume":"133","author":"Kristensen","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13277-BIB0028|bjd13277-cit-0028","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0190-9622(97)80275-7","article-title":"Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study","volume":"36","author":"Zonneveld","year":"1997","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13277","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13277\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:11:25Z","timestamp":1676383885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/3\/754\/6615915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,18]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13277","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,18]]}}}